Business
AngioDynamics to Participate in Upcoming Investor Conferences
LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy
About this update from Angiodynamics, Inc.
[{"type":"text","content":" LATHAM, N.Y.--(BUSINESS WIRE)--\nAngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced that its management is scheduled to participate in the following upcoming investor conferences:\n\n\n9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference\nDate: August 12, 2024\n\n\nCanaccord Genuity 44th Annual Growth Conference\nPresentation: August 13, 2024 at 10:00am\nA live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com.\n\n\nAbout AngioDynamics, Inc.\n\n\nAngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients.\n\n\nThe Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com.\n\nView source version on businesswire.com: https://www.businesswire.com/news/home/20240729308520/en/\n\nInvestors:\n\n\nAngioDynamics, Inc.\nStephen Trowbridge, Executive Vice President & CFO\n(518) 795-1408\n\n\nSource: AngioDynamics, Inc.","length":2924,"tagName":"div"}]